Skip Navigation


Carcinogenesis Advance Access originally published online on July 2, 2009
Carcinogenesis 2009 30(9):1591-1596; doi:10.1093/carcin/bgp159
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/9/1591    most recent
bgp159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oikarinen, S. I.
Right arrow Articles by Gould, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oikarinen, S. I.
Right arrow Articles by Gould, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Genetic mapping of Mom5, a novel modifier of ApcMin-induced intestinal tumorigenesis

Seija I. Oikarinen{dagger}, Alicia G. Cleveland1,{dagger}, Karlene M. Cork1, Kimberly K. Bynoté1, Joseph J. Rafter2, Jan-Åke Gustafsson2,3, Marja Mutanen and Karen A. Gould1,*

Department of Applied Chemistry and Microbiology (Nutrition), University of Helsinki, PO Box 66, Helsinki FIN-00014, Finland
1 Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 Nebraska Medical Center, Omaha, NE 68198, USA
2 Department of Biosciences and Nutrition, Karolinska Institute, NOVUM, S-14186 Huddinge, Sweden
3 Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA

* To whom correspondence should be addressed. Tel: +1 402 559 2456; Fax: +1 402 559 7328; Email: kagould{at}unmc.edu

Correspondence may also be addressed to Marja Mutanen. Tel: +358 9 191 58270; Fax: +358 9 191 58269; Email: marja.mutanen{at}helsinki.fi

The initial purpose of this study was to assess the role of estrogen receptor β (ERβ) in intestinal tumorigenesis by examining the effects of an ERβ knockout (ERβ–/–) on ApcMin mice. In order to accomplish this goal on a uniform genetic background, we were required to backcross the ERβ knockout from the 129P2 genetic background to the B6 genetic background for 10 generations. Midway through this process, we performed a test cross in which mice from the N5 backcross generation of the ERβ knockout strain were intercrossed with ApcMin/+ mice to obtain ApcMin/+ ERβ+/+, ApcMin/+ ERβ+/– and ApcMin/+ ERβ–/– mice. Intestinal tumorigenesis in the N5F2 mice was evaluated at 14 weeks of age. The analysis of the impact of ERβ in the N5 cross was complicated by segregating 129P2-derived alleles that affected tumor number and were unlinked to ERβ. Genetic linkage analysis of this cross permitted the localization of a single genetic modifier of tumor number in ApcMin/+ mice. This locus, Modifier of Min 5 (Mom5), maps to proximal mouse chromosome 5; the 129P2 allele of this locus is associated with a 50% reduction in mean intestinal tumor number. Through in silico analysis and confirmatory sequencing, we have identified the Rad50-interacting protein-1 gene as a strong candidate for Mom5.

Abbreviations: aa, amino acid; ERβ, estrogen receptor β; LOD, logarithm of the odds; MGI, mouse genome informatics; Mom, modifier of min; nt, nucleotide; QTL, quantitative trait locus; Rint-1, Rad50-interacting protein-1; SNP, single nucleotide polymorphism


{dagger} These authors contributed equally to this work.

Received November 6, 2008; revised June 15, 2009; accepted June 20, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.